SE8702330L - COMPOUNDS INTENDED TO BE USED AS INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 3-AMINO-2-OXO-AZETIDINE-1-SULPHONIC ACIDS - Google Patents

COMPOUNDS INTENDED TO BE USED AS INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 3-AMINO-2-OXO-AZETIDINE-1-SULPHONIC ACIDS

Info

Publication number
SE8702330L
SE8702330L SE8702330A SE8702330A SE8702330L SE 8702330 L SE8702330 L SE 8702330L SE 8702330 A SE8702330 A SE 8702330A SE 8702330 A SE8702330 A SE 8702330A SE 8702330 L SE8702330 L SE 8702330L
Authority
SE
Sweden
Prior art keywords
radical
azetidine
hydrogen atom
compound
alkyl
Prior art date
Application number
SE8702330A
Other languages
Swedish (sv)
Other versions
SE500849C2 (en
SE8702330D0 (en
Inventor
R Heymes
A Bonnet
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SE8702330D0 publication Critical patent/SE8702330D0/en
Publication of SE8702330L publication Critical patent/SE8702330L/en
Publication of SE500849C2 publication Critical patent/SE500849C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

An azetidine of formula (I): <IMAGE> or a salt thereof, in which R represents a hydrogen atom or a linear or branched, alkyl, alkenyl, or alkynyl radical having at most 12 carbon atoms, which radical is optionally substituted; R1 represents a radical -(CH2)n-X; in which n represents an integer from 1 to 4; and X represents a halogen atom; a cyano radical; a radical O-R'1 in which R'1 represents a hydrogen atom or an alkyl radical; or X represents a radical S-R''1 in which R''1 represents a hydrogen atom, an alkyl radical or a heterocyclic radical; or X represents a radical <IMAGE> in which R' and R'' are the same or different and each represents a hydrogen atom or an alkyl radical having from 1 to 4 carbon atoms, or R' and R'' together with the nitrogen atom to which they are attached form a heterocyclic radical; or X represents an azido, a thiocyanato or an isothiocyanato radical; and the wavy line indicates that the compound is in its cis or transform or in the form of a cis-trans mixture; the oxime group in the compound being in the syn form, and the compound being in the racemic or an optically active form, is a new compound. The azetidine and its pharmaceutically acceptable salts are medicaments particularly antibiotics.
SE8702330A 1981-10-23 1987-06-04 New 3-amino-2-oxo-azetidine-1-sulfonic acids, intermediates to the corresponding 3-amino-substituted-2-oxo-azetidine-1-sulfonic acids SE500849C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8119946A FR2515182B1 (en) 1981-10-23 1981-10-23 NOVEL PRODUCTS DERIVED FROM 3-AMINO 2-OXO AZETIDINE 1-SULFAMIC ACID, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS AND THE INTERMEDIATE PRODUCTS NECESSARY FOR THEIR PREPARATION

Publications (3)

Publication Number Publication Date
SE8702330D0 SE8702330D0 (en) 1987-06-04
SE8702330L true SE8702330L (en) 1987-06-04
SE500849C2 SE500849C2 (en) 1994-09-19

Family

ID=9263337

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8205870A SE461655B (en) 1981-10-23 1982-10-15 3-AMINO-2-OXO-AZETIDIN-1-SULPHONIC ACID DERIVATIVES, PREPARED FOR PREPARATION THEREOF, AND THESE DERIVATIVES FOR USE AS A MEDICINE
SE8702330A SE500849C2 (en) 1981-10-23 1987-06-04 New 3-amino-2-oxo-azetidine-1-sulfonic acids, intermediates to the corresponding 3-amino-substituted-2-oxo-azetidine-1-sulfonic acids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8205870A SE461655B (en) 1981-10-23 1982-10-15 3-AMINO-2-OXO-AZETIDIN-1-SULPHONIC ACID DERIVATIVES, PREPARED FOR PREPARATION THEREOF, AND THESE DERIVATIVES FOR USE AS A MEDICINE

Country Status (12)

Country Link
JP (2) JPS58135883A (en)
AT (1) AT382150B (en)
BE (1) BE894785A (en)
CA (1) CA1201439A (en)
CH (1) CH655317A5 (en)
DE (1) DE3239157C2 (en)
FR (1) FR2515182B1 (en)
GB (1) GB2111482B (en)
IT (1) IT1157233B (en)
LU (1) LU84434A1 (en)
NL (1) NL8204089A (en)
SE (2) SE461655B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
US4673739A (en) * 1980-12-05 1987-06-16 Takeda Chemical Industries, Ltd. 4-carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
MX7096E (en) * 1980-12-05 1987-06-19 Takeda Chemical Industries Ltd METHOD FOR PREPARATION OF 2-OXOAZETIDINE DERIVATIVES
US4675397A (en) * 1980-12-05 1987-06-23 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
US4572801A (en) * 1981-04-30 1986-02-25 Takeda Chemical Industries, Ltd. 4-Carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
FR2558467B2 (en) * 1981-10-23 1987-03-20 Roussel Uclaf NEW PRODUCT DERIVED FROM 3-AMINO 2-OXO AZETIDINE 1-SULPHAMIC ACID, ITS PREPARATION PROCESS, ITS USE AS A MEDICAMENT AND AN INTERMEDIATE PRODUCT NECESSARY FOR ITS PREPARATION
US4443374A (en) * 1982-02-01 1984-04-17 E. R. Squibb & Sons, Inc. Process for preparing (3S)-3-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]-acetyl]amino]-2-oxo-1-azetidinesulfonic acid, and 4-substituted derivatives
JPS59175490A (en) * 1983-03-24 1984-10-04 Banyu Pharmaceut Co Ltd 2-oxo-1-azetidinesulfonic acid derivative
JPS58208288A (en) * 1982-05-31 1983-12-03 Banyu Pharmaceut Co Ltd 2-oxo-1-azetidinesulfonic acid derivative
DE3377061D1 (en) * 1982-06-03 1988-07-21 Hoffmann La Roche Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
DE3372768D1 (en) * 1982-06-03 1987-09-03 Hoffmann La Roche 1-SULFO-2-OXOAZETIDINE DERIVATIVES
JPS5982359A (en) * 1982-11-02 1984-05-12 Kanegafuchi Chem Ind Co Ltd Preparation of 4(r) coordinated optically active beta-lactam compound
EP0117053A1 (en) * 1983-02-10 1984-08-29 Ajinomoto Co., Inc. Azetidinone derivatives
JPS59231086A (en) * 1983-06-15 1984-12-25 Teikoku Hormone Mfg Co Ltd 4-methoxyethyl-2-azetidinone-1-sulfonic acid derivative
US4501697A (en) * 1983-06-17 1985-02-26 E. R. Squibb & Sons, Inc. 4-[[(Amidomethyl)oxy]methyl]-2-oxo-1-azetidinesulfonic acid salts
JPS6097978A (en) * 1983-10-31 1985-05-31 Otsuka Chem Co Ltd 3-acylamino-4-methyl-2-azetidinone-1-sulfonic acid derivative, its production and drug containing said derivative
JPS60202882A (en) * 1984-03-27 1985-10-14 Teikoku Hormone Mfg Co Ltd Novel 2-azetidinone-1-sulfonic acid derivative
US4837318A (en) * 1985-05-09 1989-06-06 The Upjohn Company Carbonate substituted monobactams as antibiotics
JPS62502825A (en) * 1985-05-09 1987-11-12 ジ・アップジョン・カンパニ− Carbonate-substituted monobactams as antibiotics
DE19642530A1 (en) * 1996-10-15 1998-04-16 Bayer Ag Haloalkoximinoacetic acid amides
US6677028B1 (en) 1999-09-10 2004-01-13 3M Innovative Properties Company Retroreflective articles having multilayer films and methods of manufacturing same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166816A (en) * 1975-05-05 1979-09-04 Smithkline Corporation Methods and intermediates for preparing cis-4-oxoazetidine intermediates
DK194776A (en) * 1975-05-05 1976-11-06 Smithkline Corp ANTIBACTERIAL MEDICINES AND INTERMEDIATE PRODUCTS THEREOF
FR2361885A1 (en) * 1975-09-03 1978-03-17 Smithkline Corp ANALOGUES OF PENICILLIN, THEIR INTERMEDIARIES AND METHODS FOR OBTAINING THEM
US4085100A (en) * 1976-11-01 1978-04-18 Smithkline Corporation Intermediate for dephthaloylation of azetidinone compounds
US4144333A (en) * 1976-11-15 1979-03-13 Smithkline Corporation Monocyclic beta-lactams with antibacterial activity
EP0005507A1 (en) * 1978-05-18 1979-11-28 Ciba-Geigy Ag Process for the fragmentation of 3-(2-hydroxyimino-acetylamino)-2-oxo azetidin compounds and compounds obtained thereby
DE3069587D1 (en) * 1979-06-08 1984-12-13 Takeda Chemical Industries Ltd 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof
NZ196202A (en) * 1980-02-07 1984-07-31 Squibb & Sons Inc Beta-lactam antibiotics (of azetidine-sulphonic acid type)
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
JPS58210061A (en) 1982-05-31 1983-12-07 Takeda Chem Ind Ltd 1-sulfo-2-oxoazetidine derivative, its preparation and use
JPS58189176A (en) 1982-04-30 1983-11-04 Takeda Chem Ind Ltd 1-sulfo-2-azetidinone derivative and its preparation
JPS57131758A (en) * 1980-12-05 1982-08-14 Takeda Chem Ind Ltd 1-sulfo-2-oxoazetidine derivative, its preparation and use
DE3274981D1 (en) * 1981-10-05 1987-02-12 Squibb & Sons Inc 4-ether derivatives of 2-azetidinone-1-sulfonic acids
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
KR900005112B1 (en) * 1982-05-31 1990-07-19 반유세이야꾸 가부시끼가이샤 Process for preparing 2-oxo-1-azetidine sulfonic acid derivatives
JPS59175490A (en) * 1983-03-24 1984-10-04 Banyu Pharmaceut Co Ltd 2-oxo-1-azetidinesulfonic acid derivative
JPS58208288A (en) * 1982-05-31 1983-12-03 Banyu Pharmaceut Co Ltd 2-oxo-1-azetidinesulfonic acid derivative

Also Published As

Publication number Publication date
FR2515182A1 (en) 1983-04-29
SE500849C2 (en) 1994-09-19
CA1201439A (en) 1986-03-04
DE3239157A1 (en) 1983-05-05
DE3239157C2 (en) 1994-04-28
IT1157233B (en) 1987-02-11
JPH0730018B2 (en) 1995-04-05
SE8702330D0 (en) 1987-06-04
SE8205870D0 (en) 1982-10-15
JPS58135883A (en) 1983-08-12
NL8204089A (en) 1983-05-16
SE8205870L (en) 1983-04-24
BE894785A (en) 1983-04-22
JPH0471073B2 (en) 1992-11-12
JPH04234844A (en) 1992-08-24
SE461655B (en) 1990-03-12
GB2111482B (en) 1985-11-06
AT382150B (en) 1987-01-12
LU84434A1 (en) 1983-06-13
CH655317A5 (en) 1986-04-15
IT8249341A0 (en) 1982-10-22
GB2111482A (en) 1983-07-06
FR2515182B1 (en) 1986-05-09
ATA391182A (en) 1986-06-15

Similar Documents

Publication Publication Date Title
SE8702330D0 (en) COMPOUNDS INTENDED TO BE USED AS INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 3-AMINO-2-OXO-AZETIDINE-1-SULPHONIC ACIDS
AU7137591A (en) New derivatives having naphthalene structure, process for preparing these and pharmaceutical compositions containing them
IT1171880B (en) DERIVATIVES OF 2-AMINO-3-ACYLAMINE-6-BENZYLAMINE-PYRIDINE WITH ANTIEPILEEPTIC ACTION AND PROCEDURE FOR THEIR PRODUCTION
ES482782A1 (en) Imidazole derivatives
KR900006296A (en) Imidazoline derivatives and preparation method thereof
FI812804L (en) 2- (1,4-BENZODIOXAN-2-YLALKYL) -IMIDAZOLER ANVAENDBARA SOM ANTIDEPRESSIVE CEILING MODEL
NO890440L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ISOKINOLINE DERIVATIVES.
MX9206930A (en) NEW COMPOUNDS
ES468658A1 (en) 4-alkylthio-2-trifluoromethyl-alkanesulphonalides and derivatives thereof
ES8607265A1 (en) Derivatives of 4-(3-alkynyloxy-2-hydroxy-propyl)-piperazin-1-yl-N-phenyl acetamide, their preparation and their therapeutical use.
DK158000C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF 3- (SUBSTITUTED BENZOYL) INDOLIZINE DERIVATIVES
IL69448A (en) Process for combating phytopathogenic fungi with azolylphenoxy-tetrahydrofuran-2-ylidene methane derivatives
SE7412163L (en)
BR8602721A (en) PROCESS FOR THE PREPARATION OF BENZALDOXIMA-CARBAMATE DERIVATIVES, PESTICIDE COMPOSITES, PROCESSES FOR COMBATING PESTES AND FOR THE PREPARATION OF COMPOSITIONS
SE7706693L (en) METHODS OF PRODUCING HYDRAZINOPYRIDAZINE DERIVATIVES
ES484086A1 (en) Isopropyl amine derivatives, processes for their preparation and medicaments containing them.
DK128892A (en) BENZYLETHER DERIVATIVES
EG16489A (en) Process for the preparation of accridanone derivatives
SE8303718D0 (en) E-HOMO-EBURNAN DERIVATIVES AND A PROCESS FOR PREPARING SAME
SE7902264L (en) N, N&#39;-BIS (PHENYLCARBAMOYLMETHYL) AMIDINES AND SETS FOR PREPARING THEREOF
DE3361517D1 (en) Substituted azolylethyl-oximinoalkyl ethers, process for their preparation and their use as fungicides
ES532180A0 (en) PROCEDURE FOR PREPARING NEW SEMICARBAZIDS
SE8300686L (en) HERBICIDAL COMPOSITIONS